DX D Biotech T 5 Bull 2X ETFTBXUETF
13F holders, Q2 2026 (June 30)4holders +1
1new positions
0sold out
$32.12avg. 13F price*
At the end of Q2 2026, 4 institutions reported holding DX D Biotech T 5 Bull 2X ETF (TBXU) in their 13F filings, up 1 from Q1 2026. 1 opened new positions and 0 sold out. The largest holders were Goldman Sachs Group Inc. ($803K), Bank of America Corp. ($803K) and GTS Securities LLC ($442K).
- Company
- DX D Biotech T 5 Bull 2X ETF
- Filed as
- DIREXION SHARES ETF TRUST (Q2 2026)
- CUSIP
- 25461H101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $23K |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 706 shares bought and 1,529 shares sold, net −823 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Goldman Sachs Group Inc. | 0.00% | No change | 25,000 | $803K |
| Bank of America Corp. | 0.00% | No change | 25,000 | $803K |
| GTS Securities LLC | 0.01% | Reduce -10.0% | 13,745 | $442K |
| UBS Group AG | 0.00% | New | 706 | $23K |
"% of holder's portfolio" is TBXU's weight in each manager's 13F, not the share of DX D Biotech T 5 Bull 2X ETF the manager owns.